Dolutegravir-associated hyperglycaemia in patients with HIV

Lancet HIV. 2020 Jul;7(7):e461-e462. doi: 10.1016/S2352-3018(20)30042-4. Epub 2020 Feb 24.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Anti-HIV Agents / adverse effects*
  • Anti-HIV Agents / therapeutic use
  • Female
  • HIV Infections / drug therapy*
  • HIV Integrase Inhibitors / adverse effects*
  • HIV Integrase Inhibitors / therapeutic use
  • Heterocyclic Compounds, 3-Ring / adverse effects*
  • Heterocyclic Compounds, 3-Ring / therapeutic use
  • Humans
  • Hyperglycemia / chemically induced*
  • Male
  • Middle Aged
  • Oxazines
  • Piperazines
  • Pyridones

Substances

  • Anti-HIV Agents
  • HIV Integrase Inhibitors
  • Heterocyclic Compounds, 3-Ring
  • Oxazines
  • Piperazines
  • Pyridones
  • dolutegravir